{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:43:52Z","timestamp":1779903832615,"version":"3.53.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2021\/43\/B\/NZ7\/02855"],"award-info":[{"award-number":["2021\/43\/B\/NZ7\/02855"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["UMO-2020\/39\/D\/NZ7\/00149"],"award-info":[{"award-number":["UMO-2020\/39\/D\/NZ7\/00149"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1\\u2013156\\u201304\/503\\u201311\\u2013001"],"award-info":[{"award-number":["503\/1\\u2013156\\u201304\/503\\u201311\\u2013001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","award":["ANR-22-CE92-0073-01"],"award-info":[{"award-number":["ANR-22-CE92-0073-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejphar.2025.178099","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:11:50Z","timestamp":1756437110000},"page":"178099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Serotonin type 6 receptor inverse agonists and neutral antagonists inhibit defecation: relevance to intestinal motility disorders"],"prefix":"10.1016","volume":"1005","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5917-8749","authenticated-orcid":false,"given":"Maciej","family":"Salaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Binienda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Canale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Grychowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Soural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-8721","authenticated-orcid":false,"given":"Pawel","family":"Zajdel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178099_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/pr.118.015552","article-title":"International union of basic and clinical pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function","volume":"73","author":"Barnes","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2025.178099_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00210-008-0276-9","article-title":"Serotonin pharmacology in the gastrointestinal tract: a review","volume":"377","author":"Beattie","year":"2008","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2025.178099_bib3","first-page":"1","article-title":"Efficacy and safety of serotonin receptor ligands in the treatment of irritable bowel syndrome: a review","author":"Binienda","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejphar.2025.178099_bib4","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1073\/pnas.1600914113","article-title":"Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity","volume":"113","author":"Deraredj Nadim","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2025.178099_bib5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nchembio.1547","article-title":"Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth","volume":"10","author":"Duhr","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2025.178099_bib6","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1021\/acschemneuro.6b00090","article-title":"Novel 1H-Pyrrolo[3,2-c]quinoline based 5-HT6 receptor antagonists with potential application for the treatment of cognitive disorders associated with alzheimer's disease","volume":"7","author":"Grychowska","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178099_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172718","article-title":"5-HT6 receptor antagonism reduces defecation in rat: a potential treatment strategy for irritable bowel syndrome with diarrhea","volume":"864","author":"Hags\u00e4ter","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1124\/mol.64.6.1295","article-title":"Differences in the central nervous system distribution and pharmacology of the mouse 5-Hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling","volume":"64","author":"Hirst","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms26031160","article-title":"Interaction of the vagus nerve and serotonin in the gut\u2013brain axis","volume":"26","author":"Hwang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178099_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.gastro.2009.09.020","article-title":"Release of 5-Hydroxytryptamine from the mucosa is not required for the generation or propagation of colonic migrating motor complexes","volume":"138","author":"Keating","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2025.178099_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101846","article-title":"mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment","volume":"193","author":"Martin","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.178099_bib12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/emmm.201201410","article-title":"5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia","volume":"4","author":"Meffre","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2025.178099_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020364","article-title":"The constitutive activity of spinal 5-HT6 receptors contributes to diabetic neuropathic pain in rats","volume":"13","author":"Mokhtar","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2025.178099_bib14","doi-asserted-by":"crossref","first-page":"G1037","DOI":"10.1152\/ajpgi.00419.2006","article-title":"Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats","volume":"292","author":"Nakade","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2025.178099_bib15","first-page":"1","article-title":"Serotonin 5-HT7 receptor in the ventral hippocampus modulates the retrieval of fear memory and stress-induced efecation","volume":"19","author":"Ohmura","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib16","first-page":"S35","article-title":"Evidence-based management of irritable bowel syndrome with diarrhea","volume":"24","author":"Pimentel","year":"2018","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejphar.2025.178099_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bcp.2019.01.001","article-title":"Systemic administration of serotonin exacerbates abdominal pain and colitis via interaction with the endocannabinoid system","volume":"161","author":"Salaga","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2018.08.016","article-title":"The novel peripherally active cannabinoid type 1 and serotonin type 3 receptor agonist AM9405 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable bowel syndrome","volume":"836","author":"Salaga","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00210-015-1142-1","article-title":"Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome","volume":"388","author":"Sa\u0142aga","year":"2015","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ejphar.2025.178099_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/jpet.114.214239","article-title":"Orally available salvinorin A analog PR-38 inhibits gastrointestinal motility and reduces abdominal pain in mouse models mimicking irritable Bowel Syndrome s","volume":"350","author":"Sa\u0142aga","year":"2014","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.ejphar.2025.178099_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnins.2013.00136","article-title":"5-HT3 and 5-HT4 antagonists inhibit peristaltic contractions in guinea-pig distal colon by mechanisms independent of endogenous 5-HT","volume":"7","author":"Sia","year":"2013","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178099_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2014.04.038","article-title":"Novel mixed NOP\/MOP agonist BU08070 alleviates pain and inhibits gastrointestinal motility in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms","volume":"736","author":"Sobczak","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fncel.2015.00487","article-title":"Constitutively active 5-HT receptors: an explanation of how 5-HT antagonists inhibit gut motility in species where 5-HT is not an enteric neurotransmitter?","volume":"9","author":"Spencer","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2025.178099_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/bph.15930","article-title":"Role of 5-HT in the enteric nervous system and enteroendocrine cells","volume":"182","author":"Spencer","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/nmo.12136","article-title":"By what mechanism does ondansetron inhibit colonic migrating motor complexes: does it require endogenous serotonin in the gut wall?","volume":"25","author":"Spencer","year":"2013","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2025.178099_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.coph.2008.07.003","article-title":"Serotonergic agents and the irritable bowel syndrome: what goes wrong?","volume":"8","author":"Spiller","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178099_bib27","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/acs.jmedchem.0c02009","article-title":"Imidazopyridine-Based 5-HT6Receptor neutral antagonists: impact of N1-Benzyl and N1-Phenylsulfonyl fragments on different receptor conformational States","volume":"64","author":"Vanda","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.178099_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nm.2098","article-title":"Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis","volume":"16","author":"Yadav","year":"2010","journal-title":"Nat. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:51:48Z","timestamp":1758055908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925008532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":28,"alternative-id":["S0014299925008532"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178099","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin type 6 receptor inverse agonists and neutral antagonists inhibit defecation: relevance to intestinal motility disorders","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178099"}}